References
- Akhtar, M. S., & Swamy, M. K. (2018). Anticancer plants: Properties and application. Springer. https://doi.org/https://doi.org/10.1007/978-981-10-8548-2
- Ashtekar, S. S., Bhatia, N. M., & Bhatia, M. S. (2019). Exploration of leads from natural domain targeting HER2 in breast cancer: An in-silico approach. International Journal of Peptide Research and Therapeutics, 25(2), 659–667. https://doi.org/https://doi.org/10.1007/s10989-018-9712-y
- Bhati, S., Kaushik, V., & Singh, J. (2019). In silico identification of piperazine linked thiohydantoin derivatives as novel androgen antagonist in prostate cancer treatment. International Journal of Peptide Research and Therapeutics, 25(3), 845–860. https://doi.org/https://doi.org/10.1007/s10989-018-9734-5
- Bhoopat, L., Srichairatanakool, S., Kanjanapothi, D., Taesotikul, T., Thananchai, H., & Bhoopat, T. (2011). Hepatoprotective effects of lychee (Litchi chinensis Sonn.): A combination of antioxidant and anti-apoptotic activities. Journal of Ethnopharmacology, 136(1), 55–66. https://doi.org/https://doi.org/10.1016/j.jep.2011.03.061
- Biovia, D. S. (2017). BIOVIA discovery studio visualizer.
- Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/https://doi.org/10.3322/caac.21492
- Brito, M. A d. (2011). Pharmacokinetic study with computational tools in the medicinal chemistry course. Brazilian Journal of Pharmaceutical Sciences, 47(4), 797–805. https://doi.org/https://doi.org/10.1590/S1984-82502011000400017
- Caulfield, S. E., Davis, C. C., & Byers, K. F. (2019). Olaparib: A novel therapy for metastatic breast cancer in patients with a BRCA1/2 mutation. Journal of the Advanced Practitioner in Oncology, 10(2), 167–174.
- Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012). Correction to “admetSAR”: A comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling, 52(11), 3099–3105. https://doi.org/https://doi.org/10.1021/acs.jcim.9b00969
- Csupor-Löffler, B., Hajdú, Z., Zupkó, I., Molnár, J., Forgo, P., Vasas, A., Kele, Z., & Hohmann, J. (2011). Antiproliferative constituents of the roots of Conyza Canadensis. Planta Medica, 77(11), 1183–1188. https://doi.org/https://doi.org/10.1055/s-0030-1270714
- Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. In Chemical biology (pp. 243–250). Humana Press. https://doi.org/https://doi.org/10.1007/978-1-4939-2269-7
- Dasaroju, S., & Gottumukkala, K. M. (2014). Current trends in the research of Emblica officinalis (Amla): A pharmacological perspective. International Journal of Pharmaceutical Sciences Review and Research, 24, 150–159.
- Daze, K., & Hof, F. (2016). Molecular interaction and recognition. In Encyclopedia of physical organic chemistry, 5 Volume Set. Wiley. https://doi.org/https://doi.org/10.1002/9781118468586.epoc3001
- Gladys, R. J., Kalai Arasi, R., Elangovan, S., & Mubarak, H. (2013). Screening of siddha medicinal plants for anti cancer activity - a review. Journal of Applied Pharmaceutical Science, 3, 176–182. https://doi.org/https://doi.org/10.7324/JAPS.2013.3831
- Gleeson, M. P. (2008). Generation of a set of simple, interpretable ADMET rules of thumb. Journal of Medicinal Chemistry, 51(4), 817–834. https://doi.org/https://doi.org/10.1021/jm701122q
- Godet, I., & Gilkes, D. M. (2017). BRCA1 and BRCA2 mutations and breast cancer. Integrative Cancer Science and Therapeutics, 4, 1–17.
- Greenwell, M., & Rahman, P. K. S. (2015). Europe PMC funders group medicinal plants: Their use in anticancer treatment. International Journal of Pharmaceutical Sciences and Research, 6, 4103–4112. https://doi.org/https://doi.org/10.13040/IJPSR.0975-8232.6(10).4103-12.Medicinal
- Hacker, K., Maas, R., Kornhuber, J., Fromm, M. F., & Zolk, O. (2015). Substrate-dependent inhibition of the human organic cation transporter OCT2: A comparison of metformin with experimental substrates. PLoS One, 10(9), e0136451. https://doi.org/https://doi.org/10.1371/journal.pone.0136451
- Hassan, M., Ashraf, Z., Abbas, Q., Raza, H., & Seo, S. Y. (2018). Exploration of novel human tyrosinase inhibitors by molecular modeling, docking and simulation studies. Interdisciplinary Sciences, Computational Life Sciences, 10(1), 68–80. https://doi.org/https://doi.org/10.1007/s12539-016-0171-x
- Ikhuoria, E. B., & Bach, C. (2018). Introduction to breast carcinogenesis – symptoms, risks factors, treatment and management. European Journal of Engineering Research and Science, 3(7), 58–66. https://doi.org/https://doi.org/10.24018/ejers.2018.3.7.745
- Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44(D1), D1202–D1213. https://doi.org/https://doi.org/10.1093/nar/gkv951
- Lamothe, S. M., Guo, J., Li, W., Yang, T., & Zhang, S. (2016). The human ether-a-go-go-related gene (hERG) potassium channel represents an unusual target for protease-mediated damage. The Journal of Biological Chemistry, 291(39), 20387–20401. https://doi.org/https://doi.org/10.1074/jbc.M116.743138
- Lee, G., Choi, K., & Hwang, K. (2017). Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells. Environmental Toxicology and Pharmacology, 49, 48–57. https://doi.org/https://doi.org/10.1016/j.etap.2016.11.016
- Levitsky, D. O., & Dembitsky, V. M. (2015). Anti-breast cancer agents derived from plants. Natural Products and Bioprospecting, 5(1), 1–16. https://doi.org/https://doi.org/10.1007/s13659-014-0048-9
- Lionta, E., Spyrou, G., Vassilatis, D., & Cournia, Z. (2014). Structure-based virtual screening for drug discovery: Principles, applications and recent advances. Current Topics in Medicinal Chemistry, 14(16), 1923–1938. https://doi.org/https://doi.org/10.2174/1568026614666140929124445
- Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17. https://doi.org/https://doi.org/10.1016/j.addr.2012.09.019
- Malvia, S., Bagadi, S. A., Dubey, U. S., & Saxena, S. (2017). Epidemiology of breast cancer in Indian women. Asia-Pacific Journal of Clinical Oncology, 13(4), 289–295. https://doi.org/https://doi.org/10.1111/ajco.12661
- McCann, K. E., & Hurvitz, S. A. (2018). Advances in the use of PARP inhibitor therapy for breast cancer. Drugs in Context, 7, 212540–212530. https://doi.org/https://doi.org/10.7573/dic.212540
- Ntie-Kang, F., Mbah, J. A., Lifongo, L. L., Owono Owono, L. C., Megnassan, E., Meva'a Mbaze, L., Judson, P. N., Sippl, W., & Efange, S. M. (2013). Assessing the pharmacokinetic profile of the CamMedNP natural products database: An in silico approach. Organic and Medicinal Chemistry Letters, 3(1), 10. https://doi.org/https://doi.org/10.1186/2191-2858-3-10
- Omogbadegun, Z. O. (2013). Medicinal plants-based foods for breast cancer treatment: An ethnobotanical survey and digitization. International Journal of Medicinal Plants and Alternative Medicine, 1, 137–163.
- Pierpaoli, E., Damiani, E., Orlando, F., Lucarini, G., Bartozzi, B., Lombardi, P., Salvatore, C., Geroni, C., Donati, A., & Provinciali, M. (2015). Antiangiogenic and antitumor activities of berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma. Carcinogenesis, 36(10), 1169–1179. https://doi.org/https://doi.org/10.1093/carcin/bgv103
- Preethi, R., & Padma, P. R. (2016). Green synthesis of silver nanobioconjugates from piper betle leaves and its anticancer activity on A549 cells. International Journal of Pharmacy and Pharmaceutical Sciences, 8(9), 201–257. https://doi.org/https://doi.org/10.22159/ijpps.2016.v8i9.12993
- Quinn, R. J., Carroll, A. R., Pham, N. B., Baron, P., Palframan, M. E., Suraweera, L., Pierens, G. K., & Muresan, S. (2008). Developing a drug-like natural product library. Journal of Natural Products, 71(3), 464–468. https://doi.org/https://doi.org/10.1021/np070526y
- Rampogu, S., Son, M., Baek, A., Park, C., Rana, R. M., Zeb, A., Parameswaran, S., & Lee, K. W. (2018). Targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular modelling approaches. Computational Biology and Chemistry, 74, 327–338. https://doi.org/https://doi.org/10.1016/j.compbiolchem.2018.04.002
- Richard, T. S., Herve, A., Kamdje, N., & Mukhtar, F. (2015). Medicinal plants in breast cancer therapy. Journal of Diseases and Medicinal Plants, 1, 19–23. https://doi.org/https://doi.org/10.11648/j.jdmp.20150101.13
- Seca, A. M. L., & Pinto, D. C. G. A. (2018). Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application. International Journal of Molecular Sciences, 19(1), 263. https://doi.org/https://doi.org/10.3390/ijms19010263
- Sevrioukova, I. F., & Poulos, T. L. (2015). Current approaches for investigating and predicting cytochrome P450 3A4-ligand interactions. Advances in Experimental Medicine and Biology, 851, 229. https://doi.org/https://doi.org/10.1007/978-3-319-16009-2
- Singh, S., Sharma, B., Kanwar, S. S., & Kumar, A. (2016). Lead phytochemicals for anticancer drug development. Frontiers in Plant Science, 7, 1667–1613. https://doi.org/https://doi.org/10.3389/fpls.2016.01667
- Suganya, J., Radha, M., Naorem, D. L., & Nishandhini, M. (2014). In silico docking studies of selected flavonoids-natural healing agents against breast cancer. Asian Pacific Journal of Cancer Prevention: APJCP, 15(19), 8155–8159. https://doi.org/https://doi.org/10.7314/apjcp.2014.15.19.8155
- Sukanya, V. K., Nagaraja, P., Manokaran, S., Reddy, A. H. M., & Surana, P. (2018). Microarray meta analysis of BRCA1 mutated genes involved in breast cancer. Oalib, 05(11), 1–14. https://doi.org/https://doi.org/10.4236/oalib.1105000
- Sullivan, K., Cramer-Morales, K., McElroy, D. L., Ostrov, D. A., Haas, K., Childers, W., Hromas, R., & Skorski, T. (2016). Identification of a small molecule inhibitor of RAD52 by structure-based selection. PLoS One, 11(1), e0147230. https://doi.org/https://doi.org/10.1371/journal.pone.0147230
- Tsaioun, K., Blaauboer, B. J., Hartung, T. (2016). Food for thought … evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods. Altern. to Anim. ALTEX, 33(4), 343–358. https://doi.org/https://doi.org/10.14573/altex.1610101
- Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/https://doi.org/10.1021/jm020017n
- Verma, A. (2012). Lead finding from phyllanthus debelis with hepatoprotective potentials. Asian Pacific Journal of Tropical Biomedicine, 2, 1735–1737. https://doi.org/https://doi.org/10.1016/S2221-1691
- Viswanathan, R., Fajardo, E., Steinberg, G., Haller, M., & Fiser, A. (2019). Protein—Protein binding supersites. PLoS Computational Biology, 15, 1–17. https://doi.org/https://doi.org/10.1371/journal.pcbi.1006704
- Wang, H., Oo Khor, T., Shu, L., Su, Z.-Y., Fuentes, F., Lee, J.-H., & Tony Kong, A.-N. (2012). Plants vs. cancer: A review on natural phytochemicals in preventing and treating cancers and their druggability. Anti-Cancer Agents in Medicinal Chemistry, 12(10), 1281–1305. https://doi.org/https://doi.org/10.2174/187152012803833026
- Woźniak, Ł., Skąpska, S., & Marszałek, K. (2015). Ursolic acid-A pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules (Basel, Switzerland), 20(11), 20614–20641. https://doi.org/https://doi.org/10.3390/molecules201119721
- Zanger, U. M. (2012). Cytochrome P450 polymorphisms. In Encyclopedia of drug metabolism and interactions (pp. 1–36). Wiley.